FA
DXCM icon

FDx Advisors’s DexCom DXCM Stock Holding History

FDx Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,635
Closed -$203K – 431
2023
Q4 		$203K Buy
+1,635
New +$167K 0.02% 650
2023
Q3 		– Sell
-3,356
Closed -$431K – 669
2023
Q2 		$431K Buy
+3,356
New +$406K 0.02% 490
2022
Q3 		– Sell
-3,620
Closed -$270K – 751
2022
Q2 		$270K Buy
3,620
+508
+16% +$46.4K 0.01% 665
2022
Q1 		$398K Sell
3,112
-408
-12% -$44.6K 0.01% 568
2021
Q4 		$473K Buy
+3,520
New +$506K 0.01% 549
2020
Q3 		– Sell
-4,308
Closed -$437K – 625
2020
Q2 		$437K Buy
4,308
+880
+26% +$78.7K 0.02% 358
2020
Q1 		$231K Buy
+3,428
New +$213K 0.02% 437
2019
Q3 		– Sell
-18,392
Closed -$689K – 668
2019
Q2 		$689K Buy
18,392
+2,052
+13% +$64.5K 0.03% 414
2019
Q1 		$487K Buy
+16,340
New +$574K 0.02% 470
2018
Q4 		– Sell
-11,628
Closed -$416K – 599
2018
Q3 		$416K Buy
+11,628
New +$360K 0.02% 574
2018
Q2 		– Sell
-88,476
Closed -$1.64M – 909
2018
Q1 		$1.64M Sell
88,476
-3,808
-4% -$56.3K 0.05% 342
2017
Q4 		$1.32M Buy
92,284
+23,056
+33% +$300K 0.04% 451
2017
Q3 		$847K Buy
69,228
+22,304
+48% +$394K 0.02% 580
2017
Q2 		$858K Sell
46,924
-5,096
-10% -$94.1K 0.03% 569
2017
Q1 		$1.1M Sell
52,020
-40,504
-44% -$791K 0.03% 492
2016
Q4 		$1.38M Buy
92,524
+25,100
+37% +$445K 0.04% 412
2016
Q3 		$1.48M Buy
+67,424
New +$1.5M 0.06% 278
2015
Q3 		– Sell
-13,180
Closed -$264K – 772
2015
Q2 		$264K Sell
13,180
-7,620
-37% -$134K 0.01% 795
2015
Q1 		$325K Buy
20,800
+3,112
+18% +$47K 0.01% 1174
2014
Q4 		$243K Buy
+17,688
New +$217K 0.01% 794

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

FDx Advisors's DXCM Position: Q1 2024 in Review

FDx Advisors sold out of DexCom (DXCM) in Q1 2024, closing a stake of 1,635 shares — an estimated $203K sold.

FDx Advisors first reported a position in DXCM in Q4 2014 and held it in 20 quarters. The position peaked at $1.64M in Q1 2018. 1,034 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • FDx Advisors reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • FDx Advisors sold 1,635 DexCom shares in Q1 2024, an estimated $203K.
  • FDx Advisors first reported a position in DexCom in Q4 2014 and held it in 20 quarters.
  • FDx Advisors's DexCom position peaked at $1.64M in Q1 2018.
  • 1,034 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on FDx Advisors's 13F filing for Q1 2024, filed 3 May 2024.